Parkinson’s Europe signs new charter on workplace rights

News

Author: Roisin McCormackPublished: 6 February 2019

Prep: Cook: Serves:

Parkinson’s Europe has signed the Dying to Work Charter – a pledge protecting the workplace rights of people with serious conditions.

The charter – part of the Trade Union Congress’ wider Dying to Work campaign – has so far protected over half a million workers in the UK.

The Dying to Work campaign group, chaired by MEP Rory Palmer, is calling on the European Union to amend its current legislation.

The campaign is asking for serious conditions to be identified as a ‘protected characteristic’ – meaning employees would enjoy a protected period after diagnosis which would ensure the couldn’t be unfairly dismissed.

Russell Patten, secretary general at Parkinson’s Europe, said: “At Parkinson’s Europe, we are committed to improving employment conditions, reducing stigma and ensuring accessibility to essential services for all people with Parkinson’s disease.”

Image: Rory Palmer MEP (left) and Russell Patten, secretary general at Parkinson’s Europe (right).

To support the charter, please click here.

For more information on working with Parkinson’s please visit Parkinson’s Europe website.

Could robots replace animals in Parkinson’s medical trials?

Last Month

Next Month

Go Back

Share this story

Comments

PD in Practice

VIDEO: From diagnosis to treatment in Parkinson’s disease

Watch experts explain the benefits of deep brain stimulation

‘People believe a witch doctor will cure them’

We speak to the president of the MPDA

Fox Foundation’s new public policy unit will be “unified voice” for Parkinson’s

New merger deal to “advance key public policy priorities”

Could a sea sponge support the search for Parkinson’s disease treatments?

How could a molecule in a sea sponge help treat Parkinson’s and similar conditions? Researchers at the University of California, Los Angeles (UCLA), in the US, recently explored this question. Their findings were published in the journal ‘Science’. The team examined a molecule known as lissodendoric acid A, which appears to counteract other molecules that damage DNA, proteins and whole cells – and was recently discovered in a sea sponge. The research team used an oft-neglected compound called a cyclic allene to control a step in the chain of chemical reactions, which enabled them to create a version of the molecule in a lab. Scientists believe that the ability to synthetically produce lissodendoric acid A will help them assess whether it can inform future therapies for conditions like Parkinson’s. UCLA’s Professor Neil Garg, the corresponding author of the study, said: “We hope others will also be able to use cyclic…

Study finds just six minutes of daily exercise might delay onset of Parkinson’s disease

Regular exercise is a common therapeutic strategy for people with Parkinson’s. Now, a study from New Zealand has suggested that daily physical activity might even delay the onset of this condition. Published in ‘The Physiological Society’, the study focused on a protein called brain-derived neurotrophic factor (BDNF) – which has previously been shown to boost cognitive performance. The researchers assessed the impact of fasting and physical activity on BDNF production in 12 people aged 18 to 56. The tests involved fasting and completing exercises of varying intensity, such as cycling for six minutes, as well as combinations of both fasting and physical activity. The results showed that brief, intense exercise was the best option for increasing the production of BDNF – with the protein increasing by a factor of four to five times compared to light exercise or fasting. Because BDNF can protect the brain from cognitive decline, the findings could…

Machine learning may help predict risk of freezing of gait in Parkinson’s disease

Difficulty taking steps forward, often referred to as the freezing of gait (FOG), is a common symptom experienced by people with Parkinson’s and one that can be difficult to predict. China-based researchers suggest that machine learning – artificial intelligence (AI) that uses algorithms to analyse data – could help predict the risk of freezing of gait developing in the early stages of the condition. Their study, published in ‘npj Parkinson’s Disease’, gave laboratory and clinical data to a machine learning model brain. This information was collected from 158 adults with untreated early-stage Parkinson’s and 73 healthy adults over a five-year period. They found that the risk of FOG could be predicted with an accuracy rate of up to 78%. The study authors suggested that machine learning methods “have the potential to help predict future FOG in patients with early Parkinson’s at an individual level”.

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Email
This field is for validation purposes and should be left unchanged.

Parkinson’s Europe signs new charter on workplace rights

News

Author: Roisin McCormackPublished: 6 February 2019

Prep: Cook: Serves:

Image: Rory Palmer MEP (left) and Russell Patten, secretary general at Parkinson’s Europe (right).

Last Month

Next Month

Share this story

Comments

sponsored article

PD in Practice

VIDEO: From diagnosis to treatment in Parkinson’s disease

In my country

‘People believe a witch doctor will cure them’

Global update

Fox Foundation’s new public policy unit will be “unified voice” for Parkinson’s

Could a sea sponge support the search for Parkinson’s disease treatments?

Study finds just six minutes of daily exercise might delay onset of Parkinson’s disease

Machine learning may help predict risk of freezing of gait in Parkinson’s disease

{title}

Subscribe

Parkinson’s Europe signs new charter on workplace rights

News

Author: Roisin McCormackPublished: 6 February 2019

Image: Rory Palmer MEP (left) and Russell Patten, secretary general at Parkinson’s Europe (right).

Last Month

Next Month

Share this story

Comments

Related articles

sponsored article

PD in Practice

VIDEO: From diagnosis to treatment in Parkinson’s disease

In my country

‘People believe a witch doctor will cure them’

Global update

Fox Foundation’s new public policy unit will be “unified voice” for Parkinson’s

Could a sea sponge support the search for Parkinson’s disease treatments?

Study finds just six minutes of daily exercise might delay onset of Parkinson’s disease

Machine learning may help predict risk of freezing of gait in Parkinson’s disease

{title}

Subscribe

Sign in